MODESTI, MIKOL
 Distribuzione geografica
Continente #
AS - Asia 247
NA - Nord America 238
EU - Europa 149
SA - Sud America 57
AF - Africa 9
OC - Oceania 5
Totale 705
Nazione #
US - Stati Uniti d'America 229
CN - Cina 88
SG - Singapore 58
RU - Federazione Russa 55
IT - Italia 45
BR - Brasile 40
KR - Corea 28
VN - Vietnam 25
HK - Hong Kong 23
FI - Finlandia 9
IE - Irlanda 9
AR - Argentina 8
FR - Francia 8
DE - Germania 7
DK - Danimarca 7
ID - Indonesia 7
CA - Canada 6
GB - Regno Unito 6
IN - India 6
AU - Australia 5
EC - Ecuador 4
BD - Bangladesh 3
CL - Cile 3
IQ - Iraq 2
JP - Giappone 2
MX - Messico 2
NG - Nigeria 2
TN - Tunisia 2
TR - Turchia 2
BJ - Benin 1
CO - Colombia 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ES - Italia 1
JM - Giamaica 1
JO - Giordania 1
KW - Kuwait 1
MA - Marocco 1
PY - Paraguay 1
RO - Romania 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 705
Città #
Santa Clara 110
Singapore 47
Hefei 39
Ashburn 31
Seoul 28
Hong Kong 23
Rome 13
Beijing 11
Ho Chi Minh City 10
San Jose 10
The Dalles 10
Dublin 9
Council Bluffs 8
New York 8
Copenhagen 7
Hanoi 7
Los Angeles 6
Munich 6
Lappeenranta 5
Rio de Janeiro 5
São Paulo 5
Kent 4
Lauterbourg 4
Melbourne 4
Montreal 4
Bengaluru 3
Buffalo 3
Helsinki 3
Jakarta 3
Naples 3
Quito 3
Abuja 2
Basra 2
Boardman 2
Curitiba 2
Da Nang 2
Florence 2
Haiphong 2
Jacareí 2
Moscow 2
Mumbai 2
Santiago 2
Tokyo 2
Tunis 2
Verona 2
West Jordan 2
Ahmedabad 1
Amman 1
Ancona 1
Araraquara 1
Araçatuba 1
As Sālimīyah 1
Asunción 1
Bandung 1
Barra Mansa 1
Batna City 1
Bello 1
Birigui 1
Bologna 1
Boracéia 1
Brackenfell 1
Britânia 1
Bucharest 1
Cairo 1
Caxias do Sul 1
Chengdu 1
Commerce 1
Cotonou 1
Denver 1
Edison 1
Fortaleza 1
Frankfurt am Main 1
Fremont 1
Gary 1
Gaziantep 1
Godoy Cruz 1
Greeley 1
Guarujá 1
Guayaquil 1
Hải Dương 1
Itapevi 1
Itatiba 1
Itatinga 1
Iturama 1
Jaraguá do Sul 1
Jiutepec 1
Juazeiro do Norte 1
Kahramanmaraş 1
Kilburn 1
Kishorganj 1
La Plata 1
Lancaster 1
Lanús 1
Leandro N. Alem 1
London 1
Luziânia 1
Mauá 1
Miami 1
Milan 1
Newark 1
Totale 516
Nome #
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer 180
Clinical outcomes of abiraterone acetate (AA) or enzalutamide (E) as first-line therapy (Rx) for men aged ≥75 with metastatic castration-resistant prostate cancer (mCRPC) according to previous use of docetaxel (D) for metastatic castration-sensitive prostate cancer (mCSPC) in a multicenter international registry: A SPARTACUSS – Meet-URO 26 study 157
Clinical outcomes of volume of disease on patients receiving enzalutamide versus abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer 127
Hypoxia-Inducible Factor in Renal Cell Carcinoma: From Molecular Insights to Targeted Therapies 124
Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS-Meet-URO 26 Study 122
Totale 710
Categoria #
all - tutte 1.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.616


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202437 0 0 0 8 7 9 1 6 0 2 4 0
2024/2025272 5 14 14 24 72 60 5 2 21 4 19 32
2025/2026401 52 70 73 57 32 15 42 12 12 19 17 0
Totale 710